Vertex Pharmaceuticals (VRTX) ended the recent trading session at $407.90, demonstrating a -1.05% change from the preceding day's closing price. The stock's change was less than the S&P 500's daily ...

The girl was diagnosed with stage 2 of the disease, a status that meant her own immune system was making at least two types ...

To achieve Oracle Validated Integration, partners such as Vertex demonstrate their integrated offering aligns with Oracle integration best practices and performs as documented.

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Dr. Rubin adds that oral minoxidil may offer more consistent absorption and better results for some patients compared to topical minoxidil. “Topical minoxidil tends to have fewer systemic effects and ...

Vertex Inc. (NASDAQ: VERX) announced the launch of Kintsugi powered by Vertex, a new AI-native tax automation solution ...

Finance is fast becoming one of the most high-impact areas for AI adoption. From anomaly detection to predictive compliance, today’s AI-powered tools help turn complexity into easily digestible data ...

Liam Kelly admits to sitting on the Rangers bench “raging” in frustration as the Light Blues struggle to get it together under Russell Martin. The 2-0 defeat by Hearts at a toxic Ibrox last weekend ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline setbacks. In August 2025, Vertex’s phase II study on the oral formulation of ...

The emergence of renewable energy like wind and solar as a viable alternative to oil, gas and other fossil fuels has raised critical questions about which form of power offers the best value today — a ...

Mary Cunningham is a reporter for CBS MoneyWatch. Before joining the business and finance vertical, she worked at "60 Minutes," CBSNews.com and CBS News 24/7 as part of the CBS News Associate Program.